Anderman Jonathan's Form 4 filing
Compass Therapeutics, Inc. (CMPX) · filed Apr 8, 2025
- Accession no.
- 0001171843-25-002086
- Filed
- Apr 8, 2025
- Trade date
- Apr 7, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $30.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Anderman JonathanCIK 0002032625 | Officer (Gen Counsel & Corporate Sec) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 7, 2025 | Common Stock | PPurchaseAcquired | +20,000 | $1.54 | +$30,800 | 21,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.